You Might Like

If you have ever had to pay for medications out of pocket, you know what kind of a sting that can be financially.

Once during a period where I was without health insurance, I had to pay out of pocket for one month for medicine I have to take and I probably could have paid for a decent sized propane grill with that money.

This is why it was applauded when Donald Trump did what he could during his time as President to try and lower drug prices, which makes what Senile Joe is doing all the more confusing.

President Joe Biden’s United States Department of Health and Human Services (HHS) on Thursday stopped executive orders from his predecessor designed to significantly lower prescription drug prices for Americans, including insulin and epinephrine.

The new administration will apparently re-evaluate the executive action from President Donald Trump toward the end of March. It remains unclear if it will be reinstated.

“The HHS Thursday froze the former Trump administration’s December drug policy that requires community health centers to pass on all their insulin and epinephrine discount savings to patients,” Bloomberg Law reported Thursday. “Centers that don’t pass on the savings wouldn’t qualify for federal grants.”

“This freeze is part of the Biden administration’s large-scale effort announced this week that will scrutinize the Trump administration’s health policies,” the report noted. “If the previous administration’s policies raise ‘fact, law, or policy’ concerns, the Biden HHS will delay them and consult with the Office of Management and Budget about other actions.”

report for Bloomberg Government said the Biden administration is on a “different page” about curbing drug prices than the Trump administration, noting of the Biden team awaiting “at least a dozen lawsuits … over Trump-era moves to lower drug prices”:

Biden enters the presidency with at least a dozen lawsuits waiting over Trump-era moves to lower drug prices, an issue the new administration will likely tackle in its own way. The Department of Health and Human Services under Biden inherits challenges to rules that tie drug reimbursement to cheaper foreign drug prices and allow medication imports from Canada. It also faces complaints over Trump’s push for drugmakers to ship discounted drugs bought by low-income health centers to commercial contract pharmacies.

Read More

About The Author

Related Posts

Leave a Reply

Your email address will not be published.